Related Experiment Videos

Myocardial collagen in cardiac hypertrophy resulting from chronic aortic regurgitation

S M Goldfine1, M Peña, N M Magid

  • 1Division of Cardiovascular Pathophysiology, Cornell University Medical College, New York, NY USA.

Insights

Unlike pressure overload, aortic regurgitation-induced cardiac fibrosis in rabbits does not involve increased collagen. This suggests different therapeutic strategies may be needed for volume overload versus pressure overload heart conditions.

Area of Science:

  • Cardiology
  • Pathology
  • Biochemistry

Background:

  • Myocardial fibrosis and abnormal collagen content are hallmarks of pathological cardiac hypertrophy.
  • Pressure overload cardiac hypertrophy is associated with increased myocardial collagen.
  • Chronic aortic regurgitation (AR) can lead to congestive heart failure, with fibrosis observed in animal models.

Purpose of the Study:

  • To determine if fibrotic lesions in volume overload (AR) are collagen-based, similar to pressure overload.
  • To compare the fibrotic response in AR to that seen in pressure overload.
  • To inform the development of targeted therapies for cardiac fibrosis in different types of heart disease.

Main Methods:

  • Moderate to severe AR induced in 19 rabbits via aortic valve perforation.
  • Animals studied at three time points: onset of systolic dysfunction, 1 month post-AR, and >3 years post-AR.
  • Left ventricular collagen content assessed biochemically (hydroxyproline) and histologically (Mason's trichrome, Picro-Sirius Red).

Main Results:

  • An age-related increase in left ventricular collagen concentration was observed in rabbits.
  • No specific increase in collagen was found in animals exhibiting fibrosis after AR.
  • Fibrotic lesions in AR were not predominantly composed of excess collagen.

Conclusions:

  • Volume overload (AR) induces fibrotic lesions in the heart that differ chemically from those in pressure overload.
  • The fibrotic process in AR may not primarily involve collagen accumulation.
  • Therapeutic strategies to prevent cardiac fibrosis may need to be distinct for volume and pressure overload conditions.

Related Concept Videos